$4.68
-0.13 (-2.60%)
Analyst Consensus
Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+677.1% upside
Low Target
$21.56
Average Target
$36.33
High Target
$42.60
Current Price
$4.68
Current
$4.68
$4.68
Target
$36.33
$36.33
$21.56
$36.33 avg
$42.60
Scenario Analysis
Bear Case
$21.56
361.2%
Low target
Base Case
$36.33
+677.1%
Avg target
Bull Case
$42.60
+811.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$20.00
-76.6% from high
52-Week Low
$3.29
+42.1% from low
Target vs 52W High
$36.33
+81.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |